PODD NASDAQ
Insulet Corp.
1W: +5.0%
1M: +12.6%
3M: -12.2%
YTD: -47.0%
1Y: -53.3%
3Y: +3.5%
5Y: -50.0%
$149.83
+0.57 (+0.38%)
Weekly Expected Move ±4.4%
$136
$143
$149
$156
$162
Credit Risk of going bust: lower than 65% of companies Debt: 8.4% of company value Bonds: $39.1M held by 117 funds, 168 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.35 (down 99.1%), Insulet Corp. would be worth roughly what it owes.
Total debt $948.4M against a stock market value of $10.39B.
Distance to default 6.87 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $483.6M (short-term plus half of long-term), stock volatility 46.5%; Altman Z 5.75. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.35 (down 99.1%), Insulet Corp. would be worth roughly what it owes.
Total debt $948.4M against a stock market value of $10.39B.
Distance to default 6.87 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $483.6M (short-term plus half of long-term), stock volatility 46.5%; Altman Z 5.75. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-02-14
Earliest Filing
2026-02-03
Latest Filing
partner: 3
supplier: 2
customer: 1
Counterparties (Filed by PODD)
6 relationshipsCompanies named in PODD's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| NXP USA, Inc. | — | supplier | Extended purchase agreement and amended pricing/volume terms for components. | 2026-02-03 | View |
| NXP USA, Inc. | — | supplier | Addendum to Purchase Agreement extending term and amending pricing and volume terms | 2025-03-10 | View |
| NXP USA, Inc. | — | partner | Extended term and amended pricing terms in existing Purchase Agreement | 2024-05-20 | View |
| Amgen Inc. | AMGN | customer | Insulet Corporation entered into Amendment 21 to the Supply Agreement and a Patent Assignment and License Agreement with | 2023-06-07 | View |
| Bigfoot Biomedical, Inc. | — | partner | Patent assignment and license agreement | 2023-02-14 | View |
| Patients Pending, Ltd. | — | partner | Patent assignment and license agreement | 2023-02-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-21 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-09-16 | Officer/Director Change; Exhibits | View | |
| 2026-09-10 | Officer/Director Change | View | |
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-25 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-05-26 | Regulation FD; Exhibits | View | |
| 2026-05-21 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-04-29 | Regulation FD; Exhibits | View | |
| 2026-03-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-04 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-02-24 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2026-02-18 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-02-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-19 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-12-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-23 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-09-16 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR